Wells Fargo’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-257,083
| Closed | -$70K | – | 7884 |
|
|
2022
Q3 | $70K | Buy |
257,083
+180,630
| +236% | +$78.9K | ﹤0.01% | 4803 |
|
|
2022
Q2 | $59K | Sell |
76,453
-7,978
| -9% | -$7.11K | ﹤0.01% | 4949 |
|
|
2022
Q1 | $90K | Buy |
84,431
+5,618
| +7% | +$10.2K | ﹤0.01% | 5382 |
|
|
2021
Q4 | $149K | Buy |
78,813
+12,858
| +19% | +$30.8K | ﹤0.01% | 5434 |
|
|
2021
Q3 | $199K | Buy |
65,955
+1,377
| +2% | +$4.9K | ﹤0.01% | 5096 |
|
|
2021
Q2 | $252K | Sell |
64,578
-293,638
| -82% | -$1.22M | ﹤0.01% | 4935 |
|
|
2021
Q1 | $1.82M | Buy |
358,216
+162,777
| +83% | +$844K | ﹤0.01% | 3785 |
|
|
2020
Q4 | $799K | Buy |
195,439
+10,696
| +6% | +$52.5K | ﹤0.01% | 4189 |
|
|
2020
Q3 | $897K | Sell |
184,743
-5,919
| -3% | -$32.3K | ﹤0.01% | 3947 |
|
|
2020
Q2 | $1.06M | Buy |
190,662
+68,215
| +56% | +$312K | ﹤0.01% | 3770 |
|
|
2020
Q1 | $401K | Buy |
122,447
+62,196
| +103% | +$328K | ﹤0.01% | 4202 |
|
|
2019
Q4 | $273K | Buy |
60,251
+7,119
| +13% | +$22.5K | ﹤0.01% | 4781 |
|
|
2019
Q3 | $221K | Buy |
53,132
+5,456
| +11% | +$19.7K | ﹤0.01% | 4903 |
|
|
2019
Q2 | $181K | Buy |
47,676
+20,082
| +73% | +$82.3K | ﹤0.01% | 5028 |
|
|
2019
Q1 | $116K | Sell |
27,594
-6,359
| -19% | -$22.2K | ﹤0.01% | 5084 |
|
|
2018
Q4 | $84K | Sell |
33,953
-181,657
| -84% | -$1.06M | ﹤0.01% | 5364 |
|
|
2018
Q3 | $1.57M | Buy |
215,610
+213,241
| +9,001% | +$934K | ﹤0.01% | 3598 |
|
|
2018
Q2 | $9K | Sell |
2,369
-720
| -23% | -$3.33K | ﹤0.01% | 5989 |
|
|
2018
Q1 | $12K | Sell |
3,089
-179
| -5% | -$752 | ﹤0.01% | 5914 |
|
|
2017
Q4 | $12K | Sell |
3,268
-5,047
| -61% | -$19.1K | ﹤0.01% | 5895 |
|
|
2017
Q3 | $33K | Buy |
8,315
+757
| +10% | +$3.48K | ﹤0.01% | 5588 |
|
|
2017
Q2 | $39K | Sell |
7,558
-11,447
| -60% | -$64.3K | ﹤0.01% | 5459 |
|
|
2017
Q1 | $131K | Buy |
19,005
+200
| +1% | +$1.56K | ﹤0.01% | 5070 |
|
|
2016
Q4 | $176K | Sell |
18,805
-2,131
| -10% | -$19.2K | ﹤0.01% | 4839 |
|
|
2016
Q3 | $205K | Buy |
20,936
+15,570
| +290% | +$210K | ﹤0.01% | 4475 |
|
|
2016
Q2 | $76K | Sell |
5,366
-640
| -11% | -$9.98K | ﹤0.01% | 4990 |
|
|
2016
Q1 | $84K | Buy |
6,006
+612
| +11% | +$8.98K | ﹤0.01% | 4959 |
|
|
2015
Q4 | $110K | Buy |
5,394
+4,951
| +1,118% | +$76.4K | ﹤0.01% | 4856 |
|
|
2015
Q3 | $6K | Buy |
443
+3
| +0.7% | +$50 | ﹤0.01% | 5826 |
|
|
2015
Q2 | $7K | Sell |
440
-1,297
| -75% | -$24.9K | ﹤0.01% | 5926 |
|
|
2015
Q1 | $35K | Buy |
1,737
+1,475
| +563% | +$33K | ﹤0.01% | 5161 |
|
|
2014
Q4 | $6K | Buy |
262
+39
| +17% | +$794 | ﹤0.01% | 5822 |
|
|
2014
Q3 | $4K | Sell |
223
-122
| -35% | -$2.21K | ﹤0.01% | 5875 |
|
|
2014
Q2 | $8K | Buy |
+345
| New | +$6.08K | ﹤0.01% | 5700 |
|
Wells Fargo's AGTC Position: Q4 2022 in Review
Wells Fargo sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 257,083 shares — an estimated $70K sold.
Wells Fargo first reported a position in AGTC in Q2 2014 and held it in 34 quarters. The position peaked at $1.82M in Q1 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- Wells Fargo reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- Wells Fargo sold 257,083 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $70K.
- Wells Fargo first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 34 quarters.
- Wells Fargo's Applied Genetic Technologies Corporation position peaked at $1.82M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Wells Fargo's 13F filing for Q4 2022, filed 13 Feb 2023.